Effect of antifungal agents, lysozyme and human antimicrobial peptide LL-37 on clinical <i>Candida</i> isolates with high biofilm production.
Chen. Yi-Chun YC; Chen. Fang-Ju FJ; Lee. Chen-Hsiang CH
Key Findings
- Fluconazole plus caspofungin synergistically reduced Candida biofilms in ~61% of isolates
- Amphotericin B combined with either caspofungin or fluconazole showed little benefit and sometimes antagonism
- LL‑37 and lysozyme had no measurable anti‑biofilm activity against the tested Candida tropicalis isolate
Practical Outcomes
- For people dealing with stubborn Candida biofilm infections, the fluconazole‑caspofungin combo may be a more effective treatment option. LL‑37 should not be relied on for anti‑fungal benefits, so biohackers looking for peptide‑based immunity boosts won’t gain from this peptide in this context.
Summary
The study tested a human antimicrobial peptide called LL‑37 and some common antifungal drugs against Candida fungi that form tough biofilms. LL‑37 didn’t work against the fungal biofilms, but a drug combo of fluconazole and caspofungin showed a helpful synergistic effect in about 60% of the samples. Other drug combos were mostly ineffective or even counter‑productive.
Abstract
<b>Introduction.</b> <i>Candida</i> species can form biofilms on tissues and medical devices, making them less susceptible to antifungal agents.<b>Hypothesis/Gap Statement.</b> Antifungal combination may be an effective strategy to fight against <i>Candida</i> biofilm.<b>Aim.</b> In this study, we investigated the <i>in vitro</i> activity of fluconazole, caspofungin and amphotericin B, alone and in combination, against 17 clinical <i>Candida tropicalis</i> and 6 <i>Candida parapsilosis</i> isolates with high biofilm formation. We also tested LL-37 and lysozyme for anti-biofilm activity against a selected <i>C. tropicalis</i> isolate.<b>Methodology.</b> <i>Candida</i> biofilms were prepared using the 96-well plate-based method. The minimum biofilm eradication concentrations were determined for single and combined antifungal drugs. The activity of LL-37 and lysozyme was determined by visual reading for planktonic cells and using the XTT assay for biofilms.<b>Results.</b> Under biofilm conditions, fluconazole plus caspofungin showed synergistic effects against 60.9% (14 of 23) of the tested isolates, including 70.6% of <i>C. tropicalis</i> [fractional inhibitory concentration index (FICI), 0.26-1.03] and 33.3% of <i>C. parapsilosis</i> (FICI, 0.04-2.03) isolates. Using this combination, no antagonism was observed. Amphotericin B plus caspofungin showed no effects against 78.3% (18 of 23) of the tested isolates. Amphotericin B plus fluconazole showed no effects against 65.2% (15 of 23) of the tested isolates and may have led to antagonism against 2 <i>C</i>. <i>tropicalis</i> and 2 <i>C. parapsilosis</i> isolates. LL-37 and lysozyme had no effect on biofilms of the selected <i>C. tropicalis</i> isolate.<b>Conclusions.</b> We found that fluconazole plus caspofungin led to a synergistic effect against <i>C. tropicalis</i> and <i>C. parapsilosis</i> biofilms. The efficacy of the antifungal combination therapies of the proposed schemes against biofilm-associated <i>Candida</i> infections requires careful and constant evaluation.
Study Information
pubmed
2021
2020-11-30T00:00:00.000Z
10.1099/jmm.0.001283
6
35